No abstract available
Keywords:
c-Kit inhibition; hair depigmentation; myelosuppression; tyrosine kinase inhibitors.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aminopyridines / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Benzothiazoles / therapeutic use
-
Biomarkers / analysis
-
Bone Marrow / drug effects
-
Bone Marrow / enzymology
-
Bone Marrow / pathology
-
Cell Line, Tumor
-
Clinical Trials as Topic
-
Dasatinib
-
Gene Expression
-
Hair / drug effects
-
Hematopoietic Stem Cells / drug effects
-
Hematopoietic Stem Cells / enzymology
-
Hematopoietic Stem Cells / pathology
-
Humans
-
Indazoles
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / enzymology
-
Leukemia, Myeloid, Acute / pathology
-
Niacinamide / analogs & derivatives
-
Niacinamide / therapeutic use
-
Phenylurea Compounds / therapeutic use
-
Pigmentation / drug effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins c-kit / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-kit / genetics
-
Proto-Oncogene Proteins c-kit / metabolism
-
Pyrimidines / therapeutic use
-
Pyrroles / therapeutic use
-
Sorafenib
-
Sulfonamides / therapeutic use
-
Thiazoles / therapeutic use
-
fms-Like Tyrosine Kinase 3 / antagonists & inhibitors*
-
fms-Like Tyrosine Kinase 3 / genetics
-
fms-Like Tyrosine Kinase 3 / metabolism
Substances
-
Aminopyridines
-
Antineoplastic Agents
-
Benzothiazoles
-
Biomarkers
-
Indazoles
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Pyrroles
-
Sulfonamides
-
Thiazoles
-
Niacinamide
-
pexidartinib
-
quizartinib
-
pazopanib
-
Sorafenib
-
FLT3 protein, human
-
Proto-Oncogene Proteins c-kit
-
fms-Like Tyrosine Kinase 3
-
Dasatinib